Posted in

Genetically Engineered Immune Cells Lead to Remission in Child with Chemotherapy-Resistant Metastatic Liver Cancer

A child with metastatic liver cancer that had stopped responding to chemotherapy is now in remission after doctors treated him with genetically engineered immune cells. Twelve months later, he still appears to be cancer free, offering new hope for treating solid tumors with CAR T therapy.
A child with metastatic liver cancer that had stopped responding to chemotherapy is now in remission after doctors treated him with genetically engineered immune cells. Twelve months later, he still appears to be cancer free, offering new hope for treating solid tumors with CAR T therapy.

There’s this really cool new cancer treatment that’s been showing some amazing promise. It’s called chimeric antigen receptor (CAR) T-cell therapy, and it works by taking a patient’s own immune cells, genetically engineering them, and then putting them back into the body to fight cancer. This treatment has been used before, but mostly for blood cancers, so it’s really exciting that it’s now being used to treat other types of cancer too.

There was a recent study where a young boy with a type of liver cancer called hepatoblastoma was treated with CAR-T therapy. He had already tried chemotherapy, but the cancer had come back, so he was part of an experimental study to see if CAR-T therapy could help. The treatment involved taking his own immune cells, engineering them to target a specific protein found in liver cancer, and then putting them back into his body. And the results were amazing – after just two treatments, the cancer was in remission, and 12 months later, the boy was still cancer-free.

This is a really big deal, because hepatoblastoma is a tough cancer to treat, especially when it’s spread to other parts of the body like the lungs. The fact that CAR-T therapy was able to get rid of the cancer without causing too many side effects is really promising. Of course, more research needs to be done to see if this treatment will work for other people with solid tumors, but it’s definitely a step in the right direction. And who knows, maybe one day this treatment will be available to lots of people and will help save many lives.

[Source]